| Dear Colleague |
| Please find correspondence HERE from SPPG Pharmacy and Medicines Management team. |
SUMMARY
- If you are planning to vaccinate a care home, please complete the e-form to assure us that plans are now in place to deliver the Spring booster programme in all Care Homes.
- The PHA has issued correspondence to Care Home Managers, which provides details for LFD testing by visiting professionals to Care Homes.
- Pharmacies should continue to plan vaccination clinic dates for those homes that are experiencing an outbreak. Whether a care home outbreak is declared or not, the PHA Duty Room will continue to provide advice to Care Home Managers on further actions to take.
- Prior to the visit to a Care Home, the pharmacist clinical lead should ask the care home manager to inform them of any residents undergoing Aerosol Generating procedures.
- A claim form is available for contractors wishing to claim eligible off-site fees for clinics
delivered at Care Homes during April and May 2022. - JCVI has not included Care Home Staff as an identified cohort for the COVID-19 spring booster. However when visiting a care home to vaccinate the residents with the Spring booster, it would be possible for a community pharmacy to arrange to vaccinate the staff members who have not received their first or second primary dose or their first booster dose.
- PHA COVID-19 vaccine toolkit has now been published HERE, which aims to support organisations in promoting the Covid-19 vaccine and increasing uptake.
- MHRA recently provided an update reassuring on safety and that the vaccine can be used during pregnancy and breastfeeding which can be accessed HERE.
ACTION
- Contractors are asked to review the correspondence.
- Please complete e-form submissions as soon as you have agreed an arrangement to provide vaccinations to a Care Home.
- Contractors are reminded if they have any queries relating to the CPVS service requiring input from a Pharmacy Adviser, they should contact their local office/adviser.
- Please do not hesitate to contact the CPNI office should you require any further information.
Kind regards

GERARD GREENE
Chief Executive



